APA (7th ed.) Citation

MK, P., HS, P., JH, K., DS, L., HJ, G., AM, A. E., . . . TW, J. (2026). Hepassocin drives EGFR-dependent endothelial atherogenic activation via NOX1/ROS amplification and p38 signaling. Archives of biochemistry and biophysics, 781, 110820. https://doi.org/10.1016/j.abb.2026.110820

Chicago Style (17th ed.) Citation

MK, Pyo, et al. "Hepassocin Drives EGFR-dependent Endothelial Atherogenic Activation via NOX1/ROS Amplification and P38 Signaling." Archives of Biochemistry and Biophysics 781 (2026): 110820. https://doi.org/10.1016/j.abb.2026.110820.

MLA (9th ed.) Citation

MK, Pyo, et al. "Hepassocin Drives EGFR-dependent Endothelial Atherogenic Activation via NOX1/ROS Amplification and P38 Signaling." Archives of Biochemistry and Biophysics, vol. 781, 2026, p. 110820, https://doi.org/10.1016/j.abb.2026.110820.